Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Instituto do Câncer Infantil (ICI) is a prominent Brazilian non-profit organization dedicated to increasing cure rates and improving the quality of life for children and adolescents with cancer. Founded in 1991, the institute provides a comprehensive support system that includes medical, psychological, and social assistance for patients and their families. ICI also maintains a specialized research laboratory focused on molecular biology and genetics, aiming to advance precision medicine and early diagnosis in pediatric oncology. Through strategic partnerships with hospitals and academic institutions, the organization fosters scientific innovation and clinical excellence. It is recognized as a reference center in Latin America for its contributions to pediatric cancer research and patient advocacy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Instituto do Câncer Infantil.